Searched for
GENERIC TABLETS
Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepiness- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry right
- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategy
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST
- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...05 Aug, 2026, 12.42 AM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...04 Aug, 2026, 02.46 PM IST
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...29 Jul, 2026, 12.54 PM IST
- Levothyroxine recalled nationwide by FDA; Earlier studies claim over 20 million Americans are 'unnecessarily' taking this thyroid medicationThe FDA has recalled levothyroxine sodium nationwide due to potency standard concerns. This medication is used to treat hypothyroidism and ...29 Jul, 2026, 12.07 PM IST
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...28 Jul, 2026, 11.49 PM IST
- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...28 Jul, 2026, 03.46 PM IST
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...27 Jul, 2026, 12.52 PM IST
- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...27 Jul, 2026, 06.44 AM IST
- Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...20 Jul, 2026, 11.21 AM IST
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...20 Jul, 2026, 10.05 AM IST
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...19 Jul, 2026, 12.35 PM IST
- Dr Reddy’s pauses weight loss drug on quality fearsDr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the ...10 Jul, 2026, 05.30 AM IST
- Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concernsDr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue ...09 Jul, 2026, 01.09 PM IST
- Dr Reddy's flags quality issue in semaglutide batches, delays commercial suppliesDr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batche...09 Jul, 2026, 09.42 AM IST
- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...05 Jul, 2026, 08.32 AM IST
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...26 Jun, 2026, 01.48 PM IST
Load More
